academic article

• Life-threatening dermatologic adverse events in oncology..  Anti-cancer drugs.  25:225-234. 2014
• Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature..  Expert opinion on drug safety.  13:15-23. 2014
• A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening..  Expert review of pharmacoeconomics & outcomes research.  13:327-342. 2013
• Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis..  Prostate cancer and prostatic diseases.  16:193-203. 2013
• Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs..  Expert opinion on drug safety.  12:299-307. 2013
• Use of number needed to treat in cost-effectiveness analyses..  The Annals of pharmacotherapy.  47:380-387. 2013